We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Approves Antibiotic Vibativ for Astellas, Theravance
FDA Approves Antibiotic Vibativ for Astellas, Theravance
September 18, 2009
The FDA has approved Theravance and Astellas’ antibiotic Vibativ for complicated skin and skin structure infections (cSSSI).